Cubic Pharmaceuticals (003020.SZ): Marketing application for chloroprocaine hydrochloride API approved

Zhitong Finance APP News, Lifang Pharmaceutical (003020.SZ) announced that recently, the company received the "Chemical API Marketing Application Approval Notification" for chloroprocaine hydrochloride issued by the National Medical Products Administration. Chloroprocaine hydrochloride is a local anesthetic that can block sodium ion channels at nerve endings, preventing nerve impulses from being transmitted, thereby blocking conduction at sensory nerve endings and producing a local anesthetic effect. Its formulations are suitable for local infiltration anesthesia, peripheral nerve block anesthesia, caudal anesthesia, and epidural anesthesia.